These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1712 related articles for article (PubMed ID: 34364311)

  • 1. Ovarian follicular function is not altered by SARS-CoV-2 infection or BNT162b2 mRNA COVID-19 vaccination.
    Bentov Y; Beharier O; Moav-Zafrir A; Kabessa M; Godin M; Greenfield CS; Ketzinel-Gilad M; Ash Broder E; Holzer HEG; Wolf D; Oiknine-Djian E; Barghouti I; Goldman-Wohl D; Yagel S; Walfisch A; Hersko Klement A
    Hum Reprod; 2021 Aug; 36(9):2506-2513. PubMed ID: 34364311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of COVID-19 infection and vaccination on SARS-CoV-2 antibody titer change following ovarian stimulation: Prospective analysis of IVF outcomes.
    Shin SY; Kim JH; Kim JH; Kwon H; Park C; Choi DH; Cho SM; Shin JE
    Medicine (Baltimore); 2024 Mar; 103(11):e37349. PubMed ID: 38489720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of Covid-19 mRNA vaccine on serum anti-Müllerian hormone levels.
    Mohr-Sasson A; Haas J; Abuhasira S; Sivan M; Doitch Amdurski H; Dadon T; Blumenfeld S; Derazne E; Hemi R; Orvieto R; Afek A; Rabinovici J
    Hum Reprod; 2022 Mar; 37(3):534-541. PubMed ID: 34935913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral Vitamin D supplementation impacts gene expression in granulosa cells in women undergoing IVF.
    Makieva S; Reschini M; Ferrari S; Bonesi F; Polledri E; Fustinoni S; Restelli L; Sarais V; Somigliana E; Viganò P
    Hum Reprod; 2021 Jan; 36(1):130-144. PubMed ID: 33305818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of contamination of semen, vaginal secretions, follicular fluid and ovarian medulla with SARS-CoV-2 in patients undergoing ART.
    Kteily K; Pening D; Diaz Vidal P; Devos M; Dechene J; Op de Beeck A; Botteaux A; Janssens S; Van den Abbeel E; Goldrat O; Delbaere A; Demeestere I
    Hum Reprod; 2022 Jan; 37(2):235-241. PubMed ID: 34741508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inactivated COVID-19 vaccination does not affect in vitro fertilization outcomes in women.
    Wu Y; Cao M; Lin Y; Xu Z; Liang Z; Huang Q; Li S; Li L; Meng Y; An C; Liu H; Liu J
    Hum Reprod; 2022 Aug; 37(9):2054-2062. PubMed ID: 35876815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does mRNA SARS-CoV-2 vaccine in the follicular fluid impact follicle and oocyte performance in IVF treatments?
    Odeh-Natour R; Shapira M; Estrada D; Freimann S; Tal Y; Atzmon Y; Bilgory A; Aslih N; Abu-Raya YS; Shalom-Paz E
    Am J Reprod Immunol; 2022 May; 87(5):e13530. PubMed ID: 35220640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oocyte matched follicular fluid anti-Müllerian hormone is an excellent predictor of live birth after fresh single embryo transfer.
    Ciepiela P; Dulęba AJ; Kario A; Chełstowski K; Branecka-Woźniak D; Kurzawa R
    Hum Reprod; 2019 Nov; 34(11):2244-2253. PubMed ID: 31725884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Healthcare Workers in South Korea Maintain a SARS-CoV-2 Antibody Response Six Months After Receiving a Second Dose of the BNT162b2 mRNA Vaccine.
    Choi JH; Kim YR; Heo ST; Oh H; Kim M; Lee HR; Yoo JR
    Front Immunol; 2022; 13():827306. PubMed ID: 35173736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dynamics of Antibody Response to BNT162b2 mRNA COVID-19 Vaccine: A 7-Month Follow-Up Study.
    Olariu TR; Ursoniu S; Marincu I; Lupu MA
    Medicina (Kaunas); 2021 Dec; 57(12):. PubMed ID: 34946275
    [No Abstract]   [Full Text] [Related]  

  • 11. Gonadotrophin stimulation for in vitro fertilization significantly alters the hormone milieu in follicular fluid: a comparative study between natural cycle IVF and conventional IVF.
    von Wolff M; Kollmann Z; Flück CE; Stute P; Marti U; Weiss B; Bersinger NA
    Hum Reprod; 2014 May; 29(5):1049-57. PubMed ID: 24608520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunogenicity of the BNT162b2 COVID-19 mRNA vaccine and early clinical outcomes in patients with haematological malignancies in Lithuania: a national prospective cohort study.
    Maneikis K; Šablauskas K; Ringelevičiūtė U; Vaitekėnaitė V; Čekauskienė R; Kryžauskaitė L; Naumovas D; Banys V; Pečeliūnas V; Beinortas T; Griškevičius L
    Lancet Haematol; 2021 Aug; 8(8):e583-e592. PubMed ID: 34224668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Response to ovulation trigger is correlated to late follicular phase progesterone levels: A hypothesis explaining reduced reproductive outcomes caused by increased late follicular progesterone rise.
    Friis Wang N; Skouby SO; Humaidan P; Andersen CY
    Hum Reprod; 2019 May; 34(5):942-948. PubMed ID: 30927415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pfizer SARS-CoV-2 BNT162b2 mRNA vaccination (BNT162b2) has no adverse effect on elective oocyte cryopreservation outcomes.
    Karavani G; Chill HH; Dick A; Meirman C; Gutman-Ido E; Herzberg S; Ben-Meir A; Imbar T
    Reprod Biomed Online; 2022 Nov; 45(5):987-994. PubMed ID: 35953414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postvaccination infections among staff of a tertiary care hospital after vaccination with severe acute respiratory syndrome coronavirus 2 vector and mRNA-based vaccines.
    Brunner-Ziegler S; Spath T; Kornek G; König F; Parschalk B; Schnetzinger M; Straßl RP; Savic R; Foit A; Resch H; Thalhammer F
    Clin Microbiol Infect; 2022 Apr; 28(4):596-601. PubMed ID: 34915073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
    Akova M; Unal S
    Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Humoral immune response after different SARS-CoV-2 vaccination regimens.
    Rose R; Neumann F; Grobe O; Lorentz T; Fickenscher H; Krumbholz A
    BMC Med; 2022 Jan; 20(1):31. PubMed ID: 35057798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Humoral immunity against SARS-CoV-2 in workers of social health care centers of Castilla y León after vaccination with the BNT162b2 mRNA vaccine from Pfizer/Biontech.].
    Casas Fischer R
    Rev Esp Salud Publica; 2021 Oct; 95():. PubMed ID: 34690347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the SARS-CoV-2 Antibody Response to the BNT162b2 Vaccine in Patients Undergoing Hemodialysis.
    Yau K; Abe KT; Naimark D; Oliver MJ; Perl J; Leis JA; Bolotin S; Tran V; Mullin SI; Shadowitz E; Gonzalez A; Sukovic T; Garnham-Takaoka J; de Launay KQ; Takaoka A; Straus SE; McGeer AJ; Chan CT; Colwill K; Gingras AC; Hladunewich MA
    JAMA Netw Open; 2021 Sep; 4(9):e2123622. PubMed ID: 34473256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SARS-CoV-2 in first trimester pregnancy: a cohort study.
    la Cour Freiesleben N; Egerup P; Hviid KVR; Severinsen ER; Kolte AM; Westergaard D; Fich Olsen L; Prætorius L; Zedeler A; Christiansen AH; Nielsen JR; Bang D; Berntsen S; Ollé-López J; Ingham A; Bello-Rodríguez J; Storm DM; Ethelberg-Findsen J; Hoffmann ER; Wilken-Jensen C; Jørgensen FS; Westh H; Jørgensen HL; Nielsen HS
    Hum Reprod; 2021 Jan; 36(1):40-47. PubMed ID: 33145598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 86.